Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00041613
Status:
UNKNOWN
Last Update Posted:
2008-04-01
First Post:
2002-07-11
Brief Title:
Study to Compare the Overall Survival of Patients Receiving INGN 201 Study Drug With Patients Receiving Methotrexate
Sponsor:
Introgen Therapeutics
Organization:
Introgen Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Carcinoma Squamous Cell |
Keywords:
| Name | View |
|---|---|
| Refractory Squamous Cell Carcinoma of the Head and Neck | View |